GlaxoSmithKline Inc.
Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
---|---|---|
Advocacy as it relates to Patended Medicines Pricing Review Board and its potential impact on BC's Life Sciences and Research Community
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
|
Advanced Education, Economic Development and Trade, Health, Industry
|
Advocacy related to pharmaceutical and health sciences research
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Advanced Education, COVID-19, Health, Hospitals, Industry
|
Discussions regarding pharmaceutical and vaccine procurement, drug and vaccine listings on publicly funded programs and other issues related to access to GSK medicines
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
COVID-19, Emergency Preparedness, Government Procurement, Health, Hospitals
|
Discussions related to pharmaceutical, vaccine and other health policy generally
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
|
COVID-19
|
GSK will conduct activities related to advancement of GSK medicines and vaccines with stakeholders of the healthcare system.
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
|
Advanced Education, COVID-19, Economic Development and Trade, Emergency Preparedness, Health, Hospitals, Industry
|
GSK will meet to discuss issues related to access to GSK Medicines and Vaccines, clinical trials and advancement of the life sciences industry
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly, Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
|
Advanced Education, COVID-19, Economic Development and Trade, Emergency Preparedness, Government Procurement, Health, Hospitals, Industry
|